AAP News Vol. 14 No. 7 July 1998, p. 18
© 1998 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rachelefsky, G. S.
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Better patient education eases transiton to CFC-free asthma inhalers

Gary S. Rachelefsky M.D., FAAP

The direction and the speed of transition from metered dose inhalers (MDIs) containing chlorofluorocarbons (CFCs) to non-CFC asthma medications has stirred debate among congressional leaders, physicians and patient advocacy groups. Pediatricians' greater under standing of the issue and proper education of parents and patients can help allay concerns about the CFC phase-out and acceptability of non-CFC asthma therapies.